162 related articles for article (PubMed ID: 21430027)
1. Aberrant expression of thyroid hormone receptor beta isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma.
Tagami T; Usui T; Shimatsu A; Beniko M; Yamamoto H; Moriyama K; Naruse M
J Clin Endocrinol Metab; 2011 Jun; 96(6):E948-52. PubMed ID: 21430027
[TBL] [Abstract][Full Text] [Related]
2. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.
Ando S; Sarlis NJ; Krishnan J; Feng X; Refetoff S; Zhang MQ; Oldfield EH; Yen PM
Mol Endocrinol; 2001 Sep; 15(9):1529-38. PubMed ID: 11518802
[TBL] [Abstract][Full Text] [Related]
3. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors.
Gittoes NJ; McCabe CJ; Verhaeg J; Sheppard MC; Franklyn JA
Thyroid; 1998 Jan; 8(1):9-14. PubMed ID: 9492147
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor.
Ando S; Sarlis NJ; Oldfield EH; Yen PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5572-6. PubMed ID: 11701737
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of human thyroid hormone receptor β isoform 4.
Moriyama K; Yamamoto H; Futawaka K; Atake A; Kasahara M; Tagami T
Endocr Res; 2016; 41(1):34-42. PubMed ID: 26513165
[TBL] [Abstract][Full Text] [Related]
6. Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone.
Bogazzi F; Manetti L; Tomisti L; Rossi G; Cosci C; Sardella C; Bartalena L; Gasperi M; Macchia E; Vitti P; Martino E
Thyroid; 2006 Oct; 16(10):989-95. PubMed ID: 17042684
[TBL] [Abstract][Full Text] [Related]
7. A Patient With a Thyrotropin-Secreting Microadenoma and Resistance to Thyroid Hormone (P453T).
Teng X; Jin T; Brent GA; Wu A; Teng W; Shan Z
J Clin Endocrinol Metab; 2015 Jul; 100(7):2511-4. PubMed ID: 25867808
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β.
Macchia E; Lombardi M; Raffaelli V; Piaggi P; Macchia L; Scattina I; Martino E
Clin Endocrinol (Oxf); 2014 Dec; 81(6):921-8. PubMed ID: 25040256
[TBL] [Abstract][Full Text] [Related]
9. A case of TSH-secreting pituitary adenoma with cyclic fluctuations in serum TSH levels.
Okuma H; Hashimoto K; Ohashi T; Mihara M; Minami I; Izumiyama H; Sasaki S; Inoshita N; Nishioka H; Yamada S; Yoshimoto T
Endocr J; 2018 Jul; 65(7):737-746. PubMed ID: 29695647
[TBL] [Abstract][Full Text] [Related]
10. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.
Han R; Shen L; Zhang J; Xie J; Fang W; Sun Q; Bian L; Zhou Y; Wang S; Ning G; Wang W; Ye L
Thyroid; 2020 Sep; 30(9):1236-1244. PubMed ID: 32212919
[No Abstract] [Full Text] [Related]
13. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
14. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular features of a TSH-secreting pituitary microadenoma.
Usui T; Izawa S; Sano T; Tagami T; Nagata D; Shimatsu A; Takahashi JA; Naruse M
Pituitary; 2005; 8(2):127-34. PubMed ID: 16379036
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical characteristics of patients with thyroid-stimulating hormone-secreting pituitary adenomas from one New Zealand centre.
Elston MS; Conaglen JV
Intern Med J; 2010 Mar; 40(3):214-9. PubMed ID: 19849747
[TBL] [Abstract][Full Text] [Related]
17. A challenging TSH/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review.
Yoon JH; Choi W; Park JY; Hong AR; Kim SS; Kim HK; Kang HC
BMC Endocr Disord; 2021 Aug; 21(1):177. PubMed ID: 34461869
[TBL] [Abstract][Full Text] [Related]
18. TSH secreting pituitary adenoma.
Jha S; Kumar S
J Assoc Physicians India; 2009 Jul; 57():537-9. PubMed ID: 20329419
[TBL] [Abstract][Full Text] [Related]
19. [Thyrotropin secreting adenoma].
Kamio M
Nihon Rinsho; 1993 Oct; 51(10):2701-5. PubMed ID: 8254942
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone secretagogue receptor expression in human pituitary tumors.
Skinner MM; Nass R; Lopes B; Laws ER; Thorner MO
J Clin Endocrinol Metab; 1998 Dec; 83(12):4314-20. PubMed ID: 9851770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
